Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

Baird Medical Investment Holdings / Equity Bottom-Up

Baird Medical Investment Holdings (BDMD US)

<ul><li>Baird Medical (NASDAQ: BDMD) is an established medical device company whose mission is to enhance patient outcomes through minimally invasive precision technology and advanced diagnostic solutions.</li><li>The company is a global leader in microwave ablation treatment for thyroid tumors.</li><li>The company eventually plans to expand this treatment to cover breast nodules, liver cancer and uterine fibroids.</li></ul>

Baird Medical (NASDAQ: BDMD) is an established medical device company whose mission is to enhance patient outcomes through minimally invasive precision technology and advanced diagnostic solutions.The company is a global leader in microwave ablation treatment for thyroid tumors.The company eventually plans to expand this treatment to cover breast nodules, liver cancer and uterine fibroids.

BDMD: Baird Medical reports 6-month interim financial results for the period ending 6/30/26.

<ul>
<li>Baird Medical (NASDAQ: BDMD) is an established medical device company whose mission is to enhance patient outcomes through minimally invasive precision technology and advanced diagnostic solutions.</li>
<li>The company is a global leader in microwave ablation treatment for thyroid tumors.</li>
<li>The company eventually plans to expand this treatment to cover breast nodules, liver cancer and uterine fibroids.</li>
</ul>


Baird Medical (NASDAQ: BDMD) is an established medical device company whose mission is to enhance patient outcomes through minimally invasive precision technology and advanced diagnostic solutions.
The company is a global leader in microwave ablation treatment for thyroid tumors.
The company eventually plans to expand this treatment to cover breast nodules, liver cancer and uterine fibroids.


BDMD:  Initiation of Leading Microwave Ablation Medical Device Company...

China

Baird Medical Investment Holdings Limited operates as a holding company. The Company, through its subsidiaries, specializes in providing medical devices that are used for treatment of benign and malignant tumors, liver and lung cancer, thyroid nodules, and breast lumps. Baird Medical Investment Holdings serves patients in China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Baird Medical Investment Holdings (BDMD US)

BDMD: Baird Medical reports 6-month interim financial results for the period ending 6/30/26.

Baird Medical (NASDAQ: BDMD) is an established medical device company whose mission is to enhance patient outcomes through minimally invasive...

Zacks Small Cap Research

BDMD: Initiation of Leading Microwave Ablation Medical Device Company...

Baird Medical (NASDAQ: BDMD) is an established medical device company whose mission is to enhance patient outcomes through minimally invasive...

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)